Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2023-12-20 00:00:00 ET · period of report 2023-12-18 · accession 0001209191-23-059324 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-20 | 2023-12-18 | BBIO | Scott Randal W. | Dir | S - Sale | $40.00 | -2,000 | 9,000 | -18% | -$80.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-18 | S | D | 2,000 | $40.00 | 9,000 | I See Footnote | — | — | (F2) By Thinking Bench Capital LLC. |